Related Experiment Video
Updated: May 9, 2026
07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
[Pattern visual evoked potentials in normal-vision eyes of post-therapy amblyopia]
Manyi Xiao1, Xin Wei, Yunping Li
1Department of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011,China.
Summary
Pattern visual evoked potential (P-VEP) testing reveals persistent visual pathway deficits in amblyopic patients even after successful pleoptic therapy. These P-VEP abnormalities in amblyopic and fellow eyes suggest traditional treatments may be insufficient for full vision recovery.
Area of Science:
- Ophthalmology
- Neuroscience
- Visual Science
Context:
- Amblyopia, a common cause of reduced vision in children, is often treated with pleoptic therapy.
- Assessing the long-term functional recovery after amblyopia treatment is crucial for understanding treatment efficacy.
- Pattern visual evoked potential (P-VEP) is a non-invasive neurophysiological test used to evaluate the integrity of the visual pathway.
Purpose:
- To evaluate the clinical significance of pattern visual evoked potential (P-VEP) parameters in children with amblyopia who achieved normal visual acuity after pleoptic therapy.
- To compare P-VEP findings between unilaterally and bilaterally amblyopic children and healthy controls.
- To identify factors influencing P-VEP abnormalities in treated amblyopic eyes.
Summary:
- Sixty children (8-12 years) with treated amblyopia (unilateral n=40, bilateral n=20) and 20 controls underwent P-VEP testing.
- Significant P100 wave latency prolongation and amplitude reduction were observed in both amblyopic groups compared to controls.
- Even fellow eyes in the unilateral amblyopia group showed abnormal P-VEP findings.
- Multiple linear regression indicated P100 latency was significantly correlated with initial treatment age, baseline visual acuity, and cycloplegic refraction (R²=0.52).
Impact:
- Findings suggest that pleoptic therapy, while improving visual acuity, may not fully restore visual pathway function.
- Deficits detected by P-VEP in both treated amblyopic and fellow eyes highlight the need for potentially enhanced or alternative therapeutic strategies.
- The correlation of P-VEP latency with specific clinical factors provides insights into the neurophysiological underpinnings of residual amblyopic deficits.
